FDA Announces Amendment to Advisory Committee Notice for Nonprescription Drugs and Dermatologic/Ophthalmic Drugs

Summary

The FDA has made changes to the notice for the Nonprescription Drugs Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee, as part of its ongoing efforts to regulate nonprescription medications.